Winslow Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$290M |
| 2 |
Intuitive Surgical
ISRG
|
+$254M |
| 3 |
Abbott
ABT
|
+$226M |
| 4 |
Agilent Technologies
A
|
+$192M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$329M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$328M |
| 3 |
PX
Praxair Inc
PX
|
+$312M |
| 4 |
Hilton Worldwide
HLT
|
+$240M |
| 5 |
Edwards Lifesciences
EW
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.93% |
| 2 | Healthcare | 21.03% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 14.46% |
| 5 | Communication Services | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Starbucks
SBUX
$120B
| $0 | ﹤0.01% |
2
| – | – |
|
102
Trip.com Group
TCOM
$29.1B
| – | – |
-4
| Closed | – |
|
|
FTCH
103
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| – | – |
-1,392,115
| Closed | -$37.9M |
|
|
DLPH
104
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $0 | ﹤0.01% |
25
| – | – |
|
|
VSM
105
DELISTED
Versum Materials, Inc.
VSM
| $0 | ﹤0.01% |
3
| – | – |
|
|
PX
106
DELISTED
Praxair Inc
PX
| – | – |
-1,942,828
| Closed | -$312M |
|
|
CELG
107
DELISTED
Celgene Corp
CELG
| – | – |
-1
| Closed | – |
|
Similar funds
Winslow Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Winslow Capital Management held 107 positions worth $16.1B, down 20% from $20.2B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Winslow Capital Management withdrew a net $1.01B in Q4 2018, closing 8 positions and reducing 47 holdings. Its most notable exit was Praxair Inc, an estimated $312M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Winslow Capital Management opened a new position in Linde worth $286M.
- Winslow Capital Management's largest Q4 2018 buy was Linde: 1,833,524 shares worth $286M.
- Winslow Capital Management added most to Intuitive Surgical in Q4 2018, an estimated $254M increase.
- Winslow Capital Management's biggest Q4 2018 reduction was JPMorgan Chase, cutting an estimated $329M.
- Winslow Capital Management fully exited Praxair Inc in Q4 2018, selling an estimated $312M.
- Winslow Capital Management's ten largest holdings make up 41% of its $16.1B portfolio in Q4 2018.
- Winslow Capital Management opened 9 new positions and closed 8 in Q4 2018.
- Winslow Capital Management's portfolio value fell 20% quarter-over-quarter to $16.1B.
Based on Winslow Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.